Polyomaviruses and disease: is there more to know than viremia and viruria?

por Nickeleit, Volker, Singh, Harsharan K.
Publicado 2015

The Urinary Polyomavirus-Haufen Test: A Highly Predictive Non-Invasive Biomarker to Distinguish “Presumptive” from “Definitive” Polyomavirus Nephropathy: How to Use It—When to Use...

por Nickeleit, Volker, Davis, Vicki G., Thompson, Bawana, Singh, Harsharan K.
Publicado 2021

The two‐faced nature of BK polyomavirus: lytic infection or non‐lytic large‐T‐positive carcinoma

por Nickeleit, Volker, Singh, Harsharan K, Kenan, Daniel J, Mieczkowski, Piotr A
Publicado 2018

Polyomavirus Nephropathy: Quantitative Urinary Polyomavirus-Haufen Testing Accurately Predicts the Degree of Intrarenal Viral Disease

por Singh, Harsharan K., Reisner, Howard, Derebail, Vimal K., Kozlowski, Tomasz, Nickeleit, Volker
Publicado 2015

The oncogenic potential of BK‐polyomavirus is linked to viral integration into the human genome

por Kenan, Daniel J, Mieczkowski, Piotr A, Burger‐Calderon, Raquel, Singh, Harsharan K, Nickeleit, Volker
Publicado 2015

The 2018 Banff Working Group classification of definitive polyomavirus nephropathy: A multicenter validation study in the modern era

por Nickeleit, Volker, Singh, Harsharan K., Dadhania, Darshana, Cornea, Virgilius, El‐Husseini, Amr, Castellanos, Ana, Davis, Vicki G., Waid, Thomas, Seshan, Surya V.
Publicado 2020

The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody‐mediated rejection

por Loupy, Alexandre, Haas, Mark, Roufosse, Candice, Naesens, Maarten, Adam, Benjamin, Afrouzian, Marjan, Akalin, Enver, Alachkar, Nada, Bagnasco, Serena, Becker, Jan U., Cornell, Lynn D., Clahsen‐van Groningen, Marian C., Demetris, Anthony J., Dragun, Duska, Duong van Huyen, Jean‐Paul, Farris, Alton B., Fogo, Agnes B., Gibson, Ian W., Glotz, Denis, Gueguen, Juliette, Kikic, Zeljko, Kozakowski, Nicolas, Kraus, Edward, Lefaucheur, Carmen, Liapis, Helen, Mannon, Roslyn B., Montgomery, Robert A., Nankivell, Brian J., Nickeleit, Volker, Nickerson, Peter, Rabant, Marion, Racusen, Lorraine, Randhawa, Parmjeet, Robin, Blaise, Rosales, Ivy A., Sapir‐Pichhadze, Ruth, Schinstock, Carrie A., Seron, Daniel, Singh, Harsharan K., Smith, Rex N., Stegall, Mark D., Zeevi, Adriana, Solez, Kim, Colvin, Robert B., Mengel, Michael
Publicado 2020

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

por Sanchez, Gina A. Montealegre, Reinhardt, Adam, Ramsey, Suzanne, Wittkowski, Helmut, Hashkes, Philip J., Berkun, Yackov, Schalm, Susanne, Murias, Sara, Dare, Jason A., Brown, Diane, Stone, Deborah L., Gao, Ling, Klausmeier, Thomas, Foell, Dirk, de Jesus, Adriana A., Chapelle, Dawn C., Kim, Hanna, Dill, Samantha, Colbert, Robert A., Failla, Laura, Kost, Bahar, O’Brien, Michelle, Reynolds, James C., Folio, Les R., Calvo, Katherine R., Paul, Scott M., Weir, Nargues, Brofferio, Alessandra, Soldatos, Ariane, Biancotto, Angelique, Cowen, Edward W., Digiovanna, John J., Gadina, Massimo, Lipton, Andrew J., Hadigan, Colleen, Holland, Steven M., Fontana, Joseph, Alawad, Ahmad S., Brown, Rebecca J., Rother, Kristina I., Heller, Theo, Brooks, Kristina M., Kumar, Parag, Brooks, Stephen R., Waldman, Meryl, Singh, Harsharan K., Nickeleit, Volker, Silk, Maria, Prakash, Apurva, Janes, Jonathan M., Ozen, Seza, Wakim, Paul G., Brogan, Paul A., Macias, William L., Goldbach-Mansky, Raphaela
Publicado 2018